UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 65

Sortiert nach

Die Stiftung Emilia Guggenheim-Schnurr der Naturforschenden Gesellschaft in Basel

Mitteilungen der Naturforschenden Gesellschaften beider Basel, 2017, Vol.17, p.103

Regenass, Urs

2017

Link zum Volltext

Verfügbarkeit prüfen

Macitentan (ACT-064992), a Tissue-Targeting Endothelin Receptor Antagonist, Enhances Therapeutic Efficacy of Paclitaxel by Modulating Survival Pathways in Orthotopic Models of Metastatic Human Ovarian Cancer

Neoplasia (New York, N.Y.), 2011-02, Vol.13 (2), p.167-IN12

2011

Link zum Volltext

Verfügbarkeit prüfen

Discovery and Optimization of 4,5-Diarylisoxazoles as Potent Dual Inhibitors of Pyruvate Dehydrogenase Kinase and Heat Shock Protein 90

Journal of medicinal chemistry, 2014-12, Vol.57 (23), p.9832-9843

2014

Link zum Volltext

Verfügbarkeit prüfen

Treatment of experimental human breast cancer and lung cancer brain metastases in mice by macitentan, a dual antagonist of endothelin receptors, combined with paclitaxel

Neuro-oncology (Charlottesville, Va.), 2016-04, Vol.18 (4), p.486-496

2016

Link zum Volltext

Verfügbarkeit prüfen

Correction to “Discovery and Optimization of 4,5-Diarylisoxazoles as Potent Dual Inhibitors of Pyruvate Dehydrogenase Kinase and Heat Shock Protein 90”

Journal of medicinal chemistry, 2019-12, Vol.62 (23), p.10926-10926

2019

Link zum Volltext

Verfügbarkeit prüfen

A derivative of staurosporine (CGP 41 251) shows selectivity for protein kinase C inhibition and In vitro anti‐proliferative as well as In vivo anti‐tumor activity

International journal of cancer, 1989-05, Vol.43 (5), p.851-856

1989

Link zum Volltext

Verfügbarkeit prüfen

Macitentan, a Dual Endothelin Receptor Antagonist, in Combination with Temozolomide Leads to Glioblastoma Regression and Long-term Survival in Mice

Clinical cancer research, 2015-10, Vol.21 (20), p.4630-4641

2015

Link zum Volltext

Verfügbarkeit prüfen

Metastatic disease: A drug discovery perspective

Seminars in cancer biology, 2012-06, Vol.22 (3), p.261-271

2012

Link zum Volltext

Verfügbarkeit prüfen

[(Alkylamino)methyl]acrylophenones: Potent and Selective Inhibitors of the Epidermal Growth Factor Receptor Protein Tyrosine Kinase

Journal of medicinal chemistry, 1995-06, Vol.38 (13), p.2441-2448

1995

Link zum Volltext

Verfügbarkeit prüfen

A high-content EMT screen identifies multiple receptor tyrosine kinase inhibitors with activity on TGFβ receptor

Oncotarget, 2016-05, Vol.7 (18), p.25983-26002

2016

Link zum Volltext

Verfügbarkeit prüfen

Dianilinophthalimides: Potent and Selective, ATP-Competitive Inhibitors of the EGF-Receptor Protein Tyrosine Kinase

Journal of medicinal chemistry, 1994-04, Vol.37 (7), p.1015-1027

1994

Link zum Volltext

Verfügbarkeit prüfen

Abstract 3779: Treatment of experimental brain metastasis of human breast cancer by macitentan, a dual antagonist of endothelin receptors combined with paclitaxel

Cancer research (Chicago, Ill.), 2014-10, Vol.74 (19_Supplement), p.3779-3779

2014

Link zum Volltext

Verfügbarkeit prüfen

Stable Amplification of the S-Adenosylmethionine Decarboxylase Gene in Chinese Hamster Ovary Cells (∗)

The Journal of biological chemistry, 1995-02, Vol.270 (5), p.2124-2132

1995

Link zum Volltext

Verfügbarkeit prüfen

Antitumor Compound Testing in Glioblastoma Organotypic Brain Cultures

Journal of biomolecular screening, 2011-09, Vol.16 (8), p.805-817

2011

Link zum Volltext

Verfügbarkeit prüfen

Abstract 5481: Therapy of human LN229 glioblastoma growing in the brain of nude mice by Macitentan, a dual endothelin receptor A and B antagonist, combined with Temozolomide

Cancer research (Chicago, Ill.), 2013-04, Vol.73 (8_Supplement), p.5481-5481

2013

Link zum Volltext

Verfügbarkeit prüfen

Antivascular Therapy for Multidrug-Resistant Ovarian Tumors by Macitentan, a Dual Endothelin Receptor Antagonist

Translational oncology, 2012-02, Vol.5 (1), p.39-47

2012

Link zum Volltext

Verfügbarkeit prüfen

Abstract 4274: Characterization and drug sensitivity testing of HTS compatible cancer microtissues

Cancer research (Chicago, Ill.), 2011-04, Vol.71 (8_Supplement), p.4274-4274

2011

Link zum Volltext

Verfügbarkeit prüfen

Selective Inhibition of the Platelet-Derived Growth Factor Signal Transduction Pathway by a Protein-Tyrosine Kinase Inhibitor of the 2- Phenylaminopyrimidine Class

Proceedings of the National Academy of Sciences - PNAS, 1995-03, Vol.92 (7), p.2558-2562

1995

Link zum Volltext

Verfügbarkeit prüfen

An isogenic cell panel identifies compounds that inhibit proliferation of mTOR-pathway addicted cells by different mechanisms

Journal of biomolecular screening, 2014-01, Vol.19 (1), p.131-144

2014

Link zum Volltext

Verfügbarkeit prüfen

Abstract 601: Macitentan (ACT-064992), a tissue-targeting endothelin receptor antagonist enhances therapeutic efficacy of paclitaxel by modulating survival pathways in orthotopic models of metastatic human ovarian cancer

Cancer research (Chicago, Ill.), 2011-04, Vol.71 (8_Supplement), p.601-601

2011

Link zum Volltext

Verfügbarkeit prüfen

Macitentan (ACT-064992), a Tissue-Targeting Endothelin Receptor Antagonist, Enhances Therapeutic Efficacy of Paclitaxel by Modulating Survival Pathways in Orthotopic Models of Metastatic Human Ovarian Cancer12

Neoplasia (New York, N.Y.), 2011-02, Vol.13 (2), p.167-179

2011

Link zum Volltext

Verfügbarkeit prüfen

Protein Tyrosine Kinase and Protein Kinase C Inhibition by Fungal Anthraquinones Related to Emodin

The Journal of Antibiotics, 1995/11/25, Vol.48(11), pp.1355-1358

1995

Link zum Volltext

Verfügbarkeit prüfen

Differential inhibition of the epidermal growth factor-, platelet-derived growth factor-, and protein kinase C-mediated signal transduction pathways by the staurosporine derivative CGP 41251

Cancer research (Chicago, Ill.), 1992-10, Vol.52 (19), p.5353-5358

1992

Link zum Volltext

Verfügbarkeit prüfen

CGP 48664, a new S-adenosylmethionine decarboxylase inhibitor with broad spectrum antiproliferative and antitumor activity

Cancer research (Chicago, Ill.), 1994-06, Vol.54 (12), p.3210-3217

1994

Link zum Volltext

Verfügbarkeit prüfen

Antivascular Therapy for Multidrug-Resistant Ovarian Tumors by Macitentan, a Dual Endothelin Receptor Antagonist1

Translational oncology, 2012-02, Vol.5 (1), p.39-47

2012

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 65

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(54)
Mit Volltextzugriff
(61)

Publikationsform

Artikel
(64)
Buchkapitel
(1)

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(33)
Life Sciences & Biomedicine
(31)
Animals
(26)
Humans
(25)
Mice
(21)
Biological And Medical Sciences
(18)
Medical Sciences
(16)
Antineoplastic Agents - Pharmacology
(14)
Female
(14)
Oncology
(13)
Pharmacology. Drug Treatments
(12)
Tumor Cells, Cultured
(11)
Antineoplastic Agents
(10)
Cell Division - Drug Effects
(10)
General Aspects
(9)
Mice, Nude
(9)
Phosphorylation
(9)
Cell Line
(8)
Mice, Inbred Balb C
(8)
Pharmacology & Pharmacy
(8)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Die Stiftung Emilia Guggenheim-Schnurr der Naturforschenden Gesellschaft in Basel

Macitentan (ACT-064992), a Tissue-Targeting Endothelin Receptor Antagonist, Enhances Therapeutic Efficacy of Paclitaxel by Modulating Survival Pathways in Orthotopic Models of Metastatic Human Ovarian Cancer

Discovery and Optimization of 4,5-Diarylisoxazoles as Potent Dual Inhibitors of Pyruvate Dehydrogenase Kinase and Heat Shock Protein 90

Treatment of experimental human breast cancer and lung cancer brain metastases in mice by macitentan, a dual antagonist of endothelin receptors, combined with paclitaxel

Correction to “Discovery and Optimization of 4,5-Diarylisoxazoles as Potent Dual Inhibitors of Pyruvate Dehydrogenase Kinase and Heat Shock Protein 90”

A derivative of staurosporine (CGP 41 251) shows selectivity for protein kinase C inhibition and In vitro anti‐proliferative as well as In vivo anti‐tumor activity

Macitentan, a Dual Endothelin Receptor Antagonist, in Combination with Temozolomide Leads to Glioblastoma Regression and Long-term Survival in Mice

Metastatic disease: A drug discovery perspective

[(Alkylamino)methyl]acrylophenones: Potent and Selective Inhibitors of the Epidermal Growth Factor Receptor Protein Tyrosine Kinase

A high-content EMT screen identifies multiple receptor tyrosine kinase inhibitors with activity on TGFβ receptor

Dianilinophthalimides: Potent and Selective, ATP-Competitive Inhibitors of the EGF-Receptor Protein Tyrosine Kinase

Abstract 3779: Treatment of experimental brain metastasis of human breast cancer by macitentan, a dual antagonist of endothelin receptors combined with paclitaxel

Stable Amplification of the S-Adenosylmethionine Decarboxylase Gene in Chinese Hamster Ovary Cells (∗)

Antitumor Compound Testing in Glioblastoma Organotypic Brain Cultures

Abstract 5481: Therapy of human LN229 glioblastoma growing in the brain of nude mice by Macitentan, a dual endothelin receptor A and B antagonist, combined with Temozolomide

Antivascular Therapy for Multidrug-Resistant Ovarian Tumors by Macitentan, a Dual Endothelin Receptor Antagonist

Abstract 4274: Characterization and drug sensitivity testing of HTS compatible cancer microtissues

Selective Inhibition of the Platelet-Derived Growth Factor Signal Transduction Pathway by a Protein-Tyrosine Kinase Inhibitor of the 2- Phenylaminopyrimidine Class

An isogenic cell panel identifies compounds that inhibit proliferation of mTOR-pathway addicted cells by different mechanisms

Abstract 601: Macitentan (ACT-064992), a tissue-targeting endothelin receptor antagonist enhances therapeutic efficacy of paclitaxel by modulating survival pathways in orthotopic models of metastatic human ovarian cancer

Macitentan (ACT-064992), a Tissue-Targeting Endothelin Receptor Antagonist, Enhances Therapeutic Efficacy of Paclitaxel by Modulating Survival Pathways in Orthotopic Models of Metastatic Human Ovarian Cancer12

Protein Tyrosine Kinase and Protein Kinase C Inhibition by Fungal Anthraquinones Related to Emodin

Differential inhibition of the epidermal growth factor-, platelet-derived growth factor-, and protein kinase C-mediated signal transduction pathways by the staurosporine derivative CGP 41251

CGP 48664, a new S-adenosylmethionine decarboxylase inhibitor with broad spectrum antiproliferative and antitumor activity

Antivascular Therapy for Multidrug-Resistant Ovarian Tumors by Macitentan, a Dual Endothelin Receptor Antagonist1

Suchergebnisse filtern